NCT04901832

Brief Summary

Renal replacement therapy is a treatment option for people who have acute or chronic renal failure. A patient with increasing symptoms of renal failure is referred to a dialysis and transplantation center early in the course of progressive kidney disease. Hemodialysis is one of the most widely used dialysis procedures. Muscle cramps are the most common complication experienced by hemodialysis patients that usually develop during and in between hemodialysis therapy. These cramps appear to be the most common reason for the early termination of the hemodialysis session. \- Research Question: Is there a difference in leg muscle cramps levels between patients undergoing hemodialysis who received intradialytic stretching exercises compared to those patients who do not receive these exercises? \- Hypothesis: Leg muscle cramp levels are less among patients undergoing hemodialysis who receive intradialytic stretching exercises compared to those patients who do not receive such exercises.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 13, 2020

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 13, 2021

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 22, 2021

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

May 19, 2021

Completed
7 days until next milestone

First Posted

Study publicly available on registry

May 26, 2021

Completed
Last Updated

May 27, 2021

Status Verified

May 1, 2021

Enrollment Period

1 month

First QC Date

May 19, 2021

Last Update Submit

May 25, 2021

Conditions

Keywords

Stretching Exercises, Muscle Cramps, Hemodialysis.

Outcome Measures

Primary Outcomes (1)

  • Muscle cramp questionnaire chart

    The muscle cramp questionnaire chart is adopted to assess the level of muscle cramps during hemodialysis, before and after the intervention.

    4 week muscle cramp assessment

Study Arms (2)

Experimental Group

EXPERIMENTAL

The intervention in this group is stretching exercises with the aim of prevention and reduction of leg muscle cramps among patients undergoing hemodialysis

Other: Intradialytic stretching exercises

Control Group

NO INTERVENTION

The participants in this group used as reference group

Interventions

Exercises performed actively and passively to reduce or prevent muscle cramps during hemodialysis procedure.

Experimental Group

Eligibility Criteria

Age20 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patients with age group 20-60 years, because it is the most common age group affected by CKD and they appropriate to apply for the study program.
  • Both male and female patients who are undergoing hemodialysis and suffer from muscle cramps.
  • Patients who are receiving two or more HD sessions a week, to facilitate patients follow-up.
  • Patients who are willing to participate, because the patients' participation is voluntary.
  • Patients who are alert and able to communicate verbally, to make the program applicable and facilitate the data collection.

You may not qualify if:

  • Emergency hemodialysis patients, to avoid mal-efficient (harmlessly apply the program).
  • Patients with vascular access in a lower extremity, to avoid vascular access failure.
  • Patients with skin sores, wounds, dermatitis, or edema of the lower extremities, with a known history of deep vein thrombosis (DVT), peripheral vascular disease (PVD), or peripheral neuropathy, to prevent complications.
  • Patients who are unable to communicate, because the patients' communication is an essential part of data collection.
  • Patients who suffer from breathing difficulty, because the application of the program required patients compliance and may cause fatigue among involved patients
  • Not willing to participate, because the patients' participation is voluntary.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Al-Sadder Medical City / The Specialized Center for Kidney Diseases and Transplantation / Hemodialysis Unit

Kufa, Al Najaf, 54003, Iraq

Location

MeSH Terms

Conditions

Muscle Cramp

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Diaa K Abd-Ali, Dr.

    University of Al-Ameed. College of Nursing

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 19, 2021

First Posted

May 26, 2021

Study Start

December 13, 2020

Primary Completion

January 13, 2021

Study Completion

March 22, 2021

Last Updated

May 27, 2021

Record last verified: 2021-05

Data Sharing

IPD Sharing
Will share

Any data that does not violate ethical considerations will be obtained from the researcher.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
Starting in October 2021
Access Criteria
Researchers in medical colleges (bachelors, masters, and doctorates), the Iraqi Ministry of Higher Education and Research, and the Iraqi Ministry of Health can access the data by emailing the researcher.

Locations